<?xml version="1.0" encoding="UTF-8"?>
<p>Camostat Mesylate is a type II transmembrane serine protease (TMSPSS2) inhibitor [
 <xref rid="B62-pathogens-09-00331" ref-type="bibr">62</xref>]. Since that SARS-CoV-2 entry mechanism involving the use of cellular protease TMPRSS2, a protease inhibitor would block entry and thus could be a treatment option [
 <xref rid="B45-pathogens-09-00331" ref-type="bibr">45</xref>].
</p>
